Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 5023-5035
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.5023
Table 3 The fetal and infant outcomes in the two study groups
Infant characteristics at birth1 variables presented with n (%) or mean ± SD
Infants from HCV-infected mothers (n = 79)
Infants from healthy mothers (n = 115)
P value
Gestational weeks 39.1 ± 1.439.4 ± 1.30.11
Full-term birth74/79 (93.7)107/115 (93.0)0.86
Meconium staining positive8/79 (10.1)11/115 (9.6)> 0.99
Height at birth, cm49.0 ± 1.649.4 ± 1.00.05
Head circumference, cm33.1 ± 0.733.3 ± 0.60.03
Weight at birth, gms3105.1 ± 459.43278.3 ± 462.00.006
≤ 3250 gms49/79 (62.0)52/115 (45.2)0.02
< 2500 gms7/79 (8.9)4/115 (3.5)0.20
Small for gestational age21/79 (1.3)1/115 (0.9)> 0.99
Birth defects0/79 (0.0)0/115 (0.0)> 0.99
Apgar score < 7 at 5 min0/79 (0.0)0/115 (0.0)> 0.99
HCV-Ab (+) at birth, n (%)79/79 (100)--
Detectable HCV RNA, n (%)1/79 (1.27)--